Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy

Rapezzi, 2015, Cardiac amyloidosis: the great pretender, Heart Fail Rev, 20, 117, 10.1007/s10741-015-9480-0 Falk, 2005, Diagnosis and management of the cardiac amyloidosis, Circulation, 112, 2047, 10.1161/CIRCULATIONAHA.104.489187 Rapezzi, 2009, Systemic cardiac amyloidosis: disease profiles and clinical courses of the 3 main types, Circulation, 120, 1203, 10.1161/CIRCULATIONAHA.108.843334 Ruberg, 2012, Transthyretin (TTR) cardiac amyloidosis, Circulation, 126, 1286, 10.1161/CIRCULATIONAHA.111.078915 Martinez-Naharro, 2018, Cardiac amyloidosis, Clin Med (Lond), 18, 30, 10.7861/clinmedicine.18-2-s30 Pinney, 2013, Senile systemic amyloidosis: clinical features at presentation and outcome, Am Heart Assoc, 2, e000098, 10.1161/JAHA.113.000098 Bokhari, 2013, 99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosis, Circ Cardiovasc Imaging, 6, 195, 10.1161/CIRCIMAGING.112.000132 Bokhari, 2018, Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis, J Nucl Cardiol, 25, 181, 10.1007/s12350-016-0610-4 Castano, 2016, Multicenter study of planar technetium 99 m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis, JAMA Cardiol, 1, 880, 10.1001/jamacardio.2016.2839 Gillmore, 2016, Nonbiopsy diagnosis of cardiac transthyretin amyloidosis, Circulation, 133, 2404, 10.1161/CIRCULATIONAHA.116.021612 Perugini, 2005, Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy, J Am Coll Cardiol, 46, 1076, 10.1016/j.jacc.2005.05.073 Kubo, 2015, Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case–control study, BMC Cardiovasc Disord, 15, 53, 10.1186/s12872-015-0043-z Westermark, 1990, Fibril in senile systemic amyloidosis is derived from normal transthyretin, Proc Natl Acad Sci USA, 87, 843, 10.1073/pnas.87.7.2843 Gertz, 2005, Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18–22 April 2004, Am J Hematol, 79, 319, 10.1002/ajh.20381 Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, 128, e240 Saenger, 2011, Multicenter analytical evaluation of a high-sensitivity troponin T assay, Clin Chim Acta, 412, 748, 10.1016/j.cca.2010.12.034 Takashio, 2018, Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis, ESC Heart Fail, 5, 27, 10.1002/ehf2.12203 Corbertt, 1984, Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography, Am J Cardiol, 54, 1231, 10.1016/S0002-9149(84)80072-7 DePace, 1983, Poor R wave progression in the precordial leads: clinical implications for the diagnosis of myocardial infarction, J Am Coll Cardiol, 2, 1073, 10.1016/S0735-1097(83)80332-5 Rahman, 2004, Noninvasive diagnosis of biopsy-proven cardiac amyloidosis, J Am Coll Cardiol, 43, 410, 10.1016/j.jacc.2003.08.043 Lang, 2015, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 16, 233, 10.1093/ehjci/jev014 Kyle, 1996, The premortem recognition of systemic senile amyloidosis with cardiac involvement, Am J Med, 101, 395, 10.1016/S0002-9343(96)00229-X Tanskanen, 2008, Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study, Ann Med, 40, 232, 10.1080/07853890701842988 González-López, 2015, Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction, Eur Heart J, 36, 2585, 10.1093/eurheartj/ehv338 Ng, 2005, Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis, Arch Intern Med, 165, 1425, 10.1001/archinte.165.12.1425 Maurer, 2016, Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey), J Am Coll Cardiol, 68, 161, 10.1016/j.jacc.2016.03.596 Mohammed, 2014, Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction, JACC Heart Fail, 2, 113, 10.1016/j.jchf.2013.11.004 Grogan, 2016, Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system, J Am Coll Cardiol, 68, 1014, 10.1016/j.jacc.2016.06.033 Staerk, 2017, Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes, Circ Res, 120, 1501, 10.1161/CIRCRESAHA.117.309732 Libbey, 1983, Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis, Arch Intern Med, 143, 1549, 10.1001/archinte.1983.00350080055015 Gertz, 1988, Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain), Arch Intern Med, 148, 929, 10.1001/archinte.1988.00380040169024 Quarta, 2017, Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis, Eur Heart J, 38, 1905, 10.1093/eurheartj/ehx047 Gertz, 2015, Diagnosis, prognosis, and therapy of transthyretin amyloidosis, J Am Coll Cardiol, 66, 2451, 10.1016/j.jacc.2015.09.075 Fine, 2014, Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis, Am J Cardiol, 113, 1723, 10.1016/j.amjcard.2014.02.030 Pellikka, 1988, Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement, Arch Intern Med, 148, 662, 10.1001/archinte.1988.00380030168027 Cooper, 2007, J Am Coll Cardiol, 50, 1914, 10.1016/j.jacc.2007.09.008 Murtagh, 2005, Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement, Am J Cardiol, 95, 535, 10.1016/j.amjcard.2004.10.028 Falk, 2010, Amyloid heart disease, Prog Cardiovasc Dis, 52, 347, 10.1016/j.pcad.2009.11.007 Liu, 2013, Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy, Circ Cardiovasc Imaging, 6, 1066, 10.1161/CIRCIMAGING.113.000683 Phelan, 2012, Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis, Heart, 98, 1442, 10.1136/heartjnl-2012-302353 Damy, 2013, Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis, Amyloid, 20, 212, 10.3109/13506129.2013.825240 Fontana, 2014, Native T1 mapping in transthyretin amyloidosis, J Am Coll Cardiol Imaging, 7, 157, 10.1016/j.jcmg.2013.10.008 Dungu, 2014, CMR-based differentiation of AL and ATTR cardiac amyloidosis, J Am Coll Cardiol Imaging, 7, 133, 10.1016/j.jcmg.2013.08.015